Titre : Régulation négative

Régulation négative : Questions médicales fréquentes

Termes MeSH sélectionnés :

Intestinal Failure
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Régulation négative : Questions médicales les plus fréquentes", "headline": "Régulation négative : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Régulation négative : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-07", "dateModified": "2025-05-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Régulation négative" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Phénomènes pharmacologiques", "url": "https://questionsmedicales.fr/mesh/D000069437", "about": { "@type": "MedicalCondition", "name": "Phénomènes pharmacologiques", "code": { "@type": "MedicalCode", "code": "D000069437", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G07.690.773" } } }, "about": { "@type": "MedicalCondition", "name": "Régulation négative", "alternateName": "Down-Regulation", "code": { "@type": "MedicalCode", "code": "D015536", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Mohammad Taheri", "url": "https://questionsmedicales.fr/author/Mohammad%20Taheri", "affiliation": { "@type": "Organization", "name": "Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran." } }, { "@type": "Person", "name": "Soudeh Ghafouri-Fard", "url": "https://questionsmedicales.fr/author/Soudeh%20Ghafouri-Fard", "affiliation": { "@type": "Organization", "name": "Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran." } }, { "@type": "Person", "name": "Susumu Ohya", "url": "https://questionsmedicales.fr/author/Susumu%20Ohya", "affiliation": { "@type": "Organization", "name": "Department of Pharmacology, Graduate School of Medical Sciences, Nagoya City University, Nagoya 467-8601, Japan." } }, { "@type": "Person", "name": "Nelsy Beatriz Medina", "url": "https://questionsmedicales.fr/author/Nelsy%20Beatriz%20Medina", "affiliation": { "@type": "Organization", "name": "Instituto de Investigaciones Farmacológicas (ININFA). Facultad de Farmacia y Bioquímica. Universidad de Buenos Aires. CONICET. Buenos Aires, Argentina." } }, { "@type": "Person", "name": "María Clara Gravielle", "url": "https://questionsmedicales.fr/author/Mar%C3%ADa%20Clara%20Gravielle", "affiliation": { "@type": "Organization", "name": "Instituto de Investigaciones Farmacológicas (ININFA). Facultad de Farmacia y Bioquímica. Universidad de Buenos Aires. CONICET. Buenos Aires, Argentina. Electronic address: graviell@ffyb.uba.ar." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Overview of Physical, Neurocognitive, and Psychosocial Outcomes in Pediatric Intestinal Failure and Transplantation.", "datePublished": "2022-08-30", "url": "https://questionsmedicales.fr/article/36040624", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11894-022-00848-3" } }, { "@type": "ScholarlyArticle", "name": "Characteristics of chronic intestinal failure in the USA based on analysis of claims data.", "datePublished": "2022-07-24", "url": "https://questionsmedicales.fr/article/35726729", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jpen.2426" } }, { "@type": "ScholarlyArticle", "name": "Effects of resistance training on sarcopenia in patients with intestinal failure: A randomized controlled trial.", "datePublished": "2023-07-16", "url": "https://questionsmedicales.fr/article/37625319", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clnu.2023.07.013" } }, { "@type": "ScholarlyArticle", "name": "Efficacy of same venous route Hickman catheter replacement in patients with intestinal failure.", "datePublished": "2022-10-28", "url": "https://questionsmedicales.fr/article/37096641", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jfma.2022.10.003" } }, { "@type": "ScholarlyArticle", "name": "Body Composition and Physical Activity in Pediatric Intestinal Failure On and Off Parenteral Nutrition.", "datePublished": "2023-07-12", "url": "https://questionsmedicales.fr/article/37434279", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MPG.0000000000003884" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes physiologiques", "item": "https://questionsmedicales.fr/mesh/D010829" }, { "@type": "ListItem", "position": 3, "name": "Phénomènes pharmacologiques et toxicologiques", "item": "https://questionsmedicales.fr/mesh/D002620" }, { "@type": "ListItem", "position": 4, "name": "Phénomènes pharmacologiques", "item": "https://questionsmedicales.fr/mesh/D000069437" }, { "@type": "ListItem", "position": 5, "name": "Régulation négative", "item": "https://questionsmedicales.fr/mesh/D015536" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Régulation négative - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Régulation négative", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Régulation négative", "description": "Comment diagnostiquer une régulation négative ?\nQuels tests sont utilisés pour évaluer la régulation négative ?\nQuels biomarqueurs indiquent une régulation négative ?\nLa régulation négative est-elle visible sur des imageries ?\nPeut-on mesurer la régulation négative in vivo ?", "url": "https://questionsmedicales.fr/mesh/D015536?mesh_terms=Intestinal+Failure&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Régulation négative", "description": "Quels symptômes sont associés à la régulation négative ?\nLa régulation négative provoque-t-elle des douleurs ?\nY a-t-il des symptômes neurologiques ?\nLa régulation négative affecte-t-elle l'humeur ?\nDes symptômes métaboliques peuvent-ils apparaître ?", "url": "https://questionsmedicales.fr/mesh/D015536?mesh_terms=Intestinal+Failure&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Régulation négative", "description": "Peut-on prévenir la régulation négative ?\nL'exercice physique joue-t-il un rôle ?\nLe stress impacte-t-il la régulation négative ?\nUne bonne hygiène de vie est-elle suffisante ?\nLes vaccinations influencent-elles la régulation ?", "url": "https://questionsmedicales.fr/mesh/D015536?mesh_terms=Intestinal+Failure&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Régulation négative", "description": "Quels traitements ciblent la régulation négative ?\nLes inhibiteurs peuvent-ils aider ?\nY a-t-il des traitements naturels ?\nComment la nutrition influence-t-elle la régulation ?\nLes thérapies comportementales sont-elles efficaces ?", "url": "https://questionsmedicales.fr/mesh/D015536?mesh_terms=Intestinal+Failure&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Régulation négative", "description": "Quelles complications peuvent survenir ?\nLa régulation négative peut-elle causer des cancers ?\nY a-t-il des risques cardiovasculaires ?\nDes troubles endocriniens peuvent-ils apparaître ?\nLa régulation négative affecte-t-elle la fertilité ?", "url": "https://questionsmedicales.fr/mesh/D015536?mesh_terms=Intestinal+Failure&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Régulation négative", "description": "Quels sont les facteurs de risque principaux ?\nLe tabagisme est-il un facteur de risque ?\nL'alimentation influence-t-elle la régulation ?\nLe manque de sommeil est-il un risque ?\nLe vieillissement est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D015536?mesh_terms=Intestinal+Failure&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une régulation négative ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses d'expression génique peuvent être utilisés." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la régulation négative ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests PCR et les microarrays sont couramment utilisés pour évaluer l'expression." } }, { "@type": "Question", "name": "Quels biomarqueurs indiquent une régulation négative ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux réduits de certaines protéines ou ARN peuvent indiquer une régulation négative." } }, { "@type": "Question", "name": "La régulation négative est-elle visible sur des imageries ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, elle nécessite des analyses moléculaires pour être détectée." } }, { "@type": "Question", "name": "Peut-on mesurer la régulation négative in vivo ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des techniques comme l'imagerie par résonance magnétique fonctionnelle peuvent aider." } }, { "@type": "Question", "name": "Quels symptômes sont associés à la régulation négative ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes varient selon le contexte, mais peuvent inclure fatigue ou dysfonctionnement cellulaire." } }, { "@type": "Question", "name": "La régulation négative provoque-t-elle des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Indirectement, si elle affecte des processus biologiques liés à la douleur." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles neurologiques peuvent survenir si des gènes régulés affectent le système nerveux." } }, { "@type": "Question", "name": "La régulation négative affecte-t-elle l'humeur ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut influencer l'humeur si elle impacte des neurotransmetteurs ou hormones." } }, { "@type": "Question", "name": "Des symptômes métaboliques peuvent-ils apparaître ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la régulation négative peut perturber le métabolisme, entraînant divers symptômes." } }, { "@type": "Question", "name": "Peut-on prévenir la régulation négative ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Prévenir les facteurs de risque et maintenir un mode de vie sain peut aider." } }, { "@type": "Question", "name": "L'exercice physique joue-t-il un rôle ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut influencer positivement l'expression génique." } }, { "@type": "Question", "name": "Le stress impacte-t-il la régulation négative ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut exacerber la régulation négative de certains gènes." } }, { "@type": "Question", "name": "Une bonne hygiène de vie est-elle suffisante ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut réduire les risques, mais d'autres facteurs génétiques et environnementaux jouent aussi." } }, { "@type": "Question", "name": "Les vaccinations influencent-elles la régulation ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations peuvent moduler l'expression immunitaire, mais pas directement la régulation négative." } }, { "@type": "Question", "name": "Quels traitements ciblent la régulation négative ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques et des médicaments peuvent être utilisés pour moduler l'expression." } }, { "@type": "Question", "name": "Les inhibiteurs peuvent-ils aider ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les inhibiteurs de certaines voies de signalisation peuvent réduire la régulation négative." } }, { "@type": "Question", "name": "Y a-t-il des traitements naturels ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certaines plantes médicinales peuvent influencer l'expression génique, mais des études sont nécessaires." } }, { "@type": "Question", "name": "Comment la nutrition influence-t-elle la régulation ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut moduler l'expression des gènes et réduire la régulation négative." } }, { "@type": "Question", "name": "Les thérapies comportementales sont-elles efficaces ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent aider à gérer les symptômes associés, mais ne ciblent pas directement la régulation." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des maladies chroniques ou des troubles métaboliques peuvent résulter d'une régulation négative prolongée." } }, { "@type": "Question", "name": "La régulation négative peut-elle causer des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une régulation négative de gènes suppresseurs de tumeurs peut augmenter le risque de cancer." } }, { "@type": "Question", "name": "Y a-t-il des risques cardiovasculaires ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déséquilibres dans l'expression génique peuvent contribuer à des maladies cardiovasculaires." } }, { "@type": "Question", "name": "Des troubles endocriniens peuvent-ils apparaître ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la régulation négative peut affecter les hormones et entraîner des troubles endocriniens." } }, { "@type": "Question", "name": "La régulation négative affecte-t-elle la fertilité ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut perturber l'équilibre hormonal et affecter la fertilité chez les individus." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque principaux ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs génétiques, environnementaux et le mode de vie peuvent influencer la régulation négative." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut induire une régulation négative de gènes liés à la santé pulmonaire." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle la régulation ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation déséquilibrée peut affecter l'expression génique et la régulation." } }, { "@type": "Question", "name": "Le manque de sommeil est-il un risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le manque de sommeil peut perturber la régulation des gènes liés au stress et à la santé." } }, { "@type": "Question", "name": "Le vieillissement est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut affecter la régulation négative des gènes, augmentant les risques de maladies." } } ] } ] }

Sources (10000 au total)

Overview of Physical, Neurocognitive, and Psychosocial Outcomes in Pediatric Intestinal Failure and Transplantation.

Intestinal failure and transplantation may significantly impact physical, neurocognitive, and psychosocial development in pediatric patients. Currently, there is a paucity of literature on the effects... Psychological disorders, neurodevelopmental delay, and social maladaptation are frequently encountered in this patient population. While the main focus is often on medical management, equal emphasis s...

Characteristics of chronic intestinal failure in the USA based on analysis of claims data.

This study investigated the prevalence, characteristics, and management of patients with chronic intestinal failure (CIF) in the United States in 2012-2020, based on parenteral support (PS) prescripti... Patients with CIF were identified from the Integrated DataVerse® claims database if they had at least two PS prescriptions within 6 months and a relevant diagnosis. Analysis included prevalence and ch... Up to 24,048 patients with CIF were identified, equivalent to 75 patients per million. CIF affected people of all ages, being more prevalent in women than in men. Many providers signed PS orders for s... Healthcare disparities for patients with CIF have likely been obscured by the lack of CIF-specific diagnostic and procedure codes, obliging providers to code for their patients under other codes. Effe...

Effects of resistance training on sarcopenia in patients with intestinal failure: A randomized controlled trial.

The potential effects of resistance training on sarcopenia in patients with intestinal failure (IF) are not fully elucidated. This study aimed to explore the efficacy of a resistance training program ... A single-center randomized controlled trial was conducted in a Chinese tertiary teaching hospital. Patients with IF exhibiting sarcopenia were randomly assigned to the exercise group or control group.... A total of 60 participants (control group 30, age 51.2 ± 12.9 years, women 43.3%; exercise group 30, age 53.9 ± 14.5 years, women 56.7%) completed the 4-week intervention trial. For the primary outcom... In this randomized clinical trial, we observed that 4 weeks of resistance training was associated with improved ASMI, physical performance, biochemical parameters (including IGF-1, prealbumin, and hem... www.chictr.org.cn, identifier: ChiCTR2100051727....

Efficacy of same venous route Hickman catheter replacement in patients with intestinal failure.

Periodical replacement of venous Hickman catheters is required for the nutritional care of patients with intestinal failure. The conventional de novo operation (DN-OP) involves inserting the catheter ... We conducted a retrospective study to compare the efficacy of Hickman catheters and the survival of venous vessels using two different operative strategies.... Overall, 181 catheters were inserted, 109 using DN-OP and 72 using SR-OP. The mean catheter duration was 11.9 ± 8.8 months in the DN-OP group and 10.5 ± 5.6 months in the SR-OP group; the infection ra... Application of SR-OP in Hickman catheter replacement significantly extended the working duration of venous access by re-using the same venous route without compromising catheter efficacy in patients w...

Body Composition and Physical Activity in Pediatric Intestinal Failure On and Off Parenteral Nutrition.

Data on the relationship between body composition (BC) and physical activity (PA) in children with intestinal failure (IF) are lacking. The objectives were to collect data on PA and BC in children wit... Cross-sectional study in children 5-18 years with IF including those receiving parenteral nutrition (PN) and those fully enterally fed. PA levels were measured using accelerometry. BC was measured by ... Fifty-eight children with IF (38 males), mean (SD) age of 10.0 (3.5) years, 20 dependent on PN were included. Patients with IF had significantly fewer steps per day ( P ≤ 0.001) compared with literatu... Children with IF, those receiving PN and those fully enterally fed, are at risk of decreased PA and altered BC. PA should be part of ongoing rehabilitation and management to optimize outcomes....

Factors Associated With Chronic Intestinal Inflammation Resembling Inflammatory Bowel Disease in Pediatric Intestinal Failure: A Matched Case-Control Study.

There is a subset of intestinal failure patients with associated chronic intestinal inflammation resembling inflammatory bowel disease. This study aimed to evaluate factors associated with chronic int... This was a single-center retrospective case-control study of children <18 years old with intestinal failure. Cases were defined by abnormal amounts of chronic intestinal inflammation on biopsies. Chil... Thirty cases were identified and matched to 60 controls. On univariate analysis, longer parenteral nutrition (PN) duration (1677 vs 834 days, P = 0.03), current PN use (33.3% vs 20.0%, P = 0.037), and... PN dependence and intestinal dysbiosis are associated with chronic intestinal inflammation in children with intestinal failure. Severity of inflammation is associated with escalation of therapy. Furth...

Motility disorders in children with intestinal failure: a national tertiary referral center experience.

Intestinal dysmotility (ID) problems are common in patients with pediatric-onset intestinal failure (IF) and short bowel syndrome (SBS), leading to significant morbidity and delays in the advancement ... Retrospective chart review of all children with IF and/or SBS who required parenteral nutrition (PN) > 6 weeks or small-intestinal resection ≥ 50%. Patients were divided into SBS and non-SBS groups. S... A total of 42 children with IF were treated in our institution during 2003-2022. In non-SBS group (n = 10), ID was the most common cause of IF (80%). SBS-group included 32 children; 18 children (56%) ... ID is the most common complication of SBS and is the most common cause of IF in non-SBS patients. ID has a high morbidity rate and various clinical manifestations. Successful treatment of these infant...

Muscle Strength, Agility, and Body Composition in Children With Intestinal Failure on Parenteral Nutrition.

With increasing number of children with intestinal failure (IF) on long-term parenteral nutrition (PN), this study assesses the impact of IF on muscle strength, speed, and agility and body composition... Cross-sectional study in children 5-18 years with IF on PN. Assessments included Bruininks-Oseretsky Test of Motor Proficiency-2 strength and agility subtest (BOT-2), and grip strength. BC data from d... Twenty-one children with IF (14 males), median age 8.33 (IQR: 6.96-11.04) years and 33 controls (20 males), 8.25 (6.67-10.79) years were included. Strength and agility ( P &lt; 0.001) and grip strengt... Children with IF are at risk of decreased muscle strength and agility, along with altered BC. Ongoing medical, nutritional, and rehabilitation intervention is vital to optimize outcomes....

Approximately 50% of acute intestinal failure (AIF) patients on short-term parenteral nutrition (PN) have intestinal failure-associated liver disease (IFALD) without effect on hospital length of stay and mortality.

Patients with intestinal failure (IF) are often dependent on PN for provision of calories and nutrients for survival. Similar to chronic intestinal failure (CIF) patients, those who have AIF are also ... The primary objective of this study was to determine the incidence of IFALD in AIF patients on short-term PN. Secondary objectives were to analyse patient and PN risk factors of IFALD, and clinical ou... This was a retrospective cross-sectional cohort study of hospitalised adult patients with AIF prescribed with short-term PN. All adult patients aged 21 years and above who received PN for at least 5 c... A total of 171 patients were enrolled in this study, with 77 (45%) having deranged LFTs at the end of PN therapy and categorised under the IFLAD group. The patient cohort was predominantly male (92 [5... In this study, IFALD is a common phenomenon in AIF and the incidence was found to be an estimated 50% amongst patients on short-term PN with similar clinical outcomes between the two groups....

Effects of Teduglutide on Diarrhea in Pediatric Patients with Short Bowel Syndrome-Associated Intestinal Failure.

This post-hoc analysis evaluated the effect of teduglutide treatment on diarrhea in patients with short bowel syndrome-associated intestinal failure (SBS-IF).... Data from 2 open-label, multicenter, phase 3 pediatric SBS-IF clinical trials of teduglutide (NCT01952080 and NCT02682381) were pooled where possible. The primary objective was to evaluate the change ... Overall, 101 patients were analyzed. Among the total teduglutide group (n = 87), there were significant changes from baseline to weeks 12 and 24 in mean (standard error) Bristol Stool Form Scale (BSFS... In this post-hoc analysis, short-term treatment with teduglutide was associated with improved stool consistency, as well as trends towards reductions in PN/IV requirements and advancements in enteral ...